Can a common antidepressant help your immune system fight colorectal cancer before surgery?
Treatments studied
Part of Cancer, Digestive system, Mental health clinical trials.
This trial is testing whether a common antidepressant called fluoxetine (Prozac) can help your immune system fight colorectal cancer before surgery. It's for people with early-stage colorectal cancer who have not yet had treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have colorectal cancer that has not spread to other parts of the body and you have not yet started treatment (like chemotherapy) before surgery.
- You are not currently taking any antidepressant medications, including Prozac or similar drugs.
- Your heart's electrical activity (QTc interval) is normal, based on an EKG test.
- You have not had another cancer (except some skin cancers) in the last 5 years.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether giving a flu vaccine directly into the tumor along with an immunotherapy drug (pembrolizumab) before surgery can help the immune system fight colorectal cancer better. It is for people with early-stage colorectal cancer that has not spread and who are scheduled for surgery.
This trial tests whether giving two immunotherapy drugs before surgery can help shrink colon cancer and improve outcomes. It is for people with a specific type of colon cancer that is planned for surgery.
This trial looks at how your immune cells change before and after surgery for colorectal cancer, and whether those changes affect your long-term recovery. It may help doctors predict outcomes and improve care.
This trial tests putting a chemo drug (fluorouracil) directly into the colon through a tube. It's for people with colorectal cancer who are already getting other cancer treatment, to see if adding local chemo helps shrink the main tumor.
This trial tests treatments given before surgery for colorectal cancer that has not spread. The goal is to shrink the tumor and improve surgical outcomes. It may be an option for patients with stage II or III colorectal cancer who have not had prior treatment.
This trial tests whether adding a short course of antibiotics to your standard first chemotherapy for stage 4 colorectal cancer can improve treatment. The antibiotics target certain gut bacteria that might affect how well the chemo works.
Hear when a new Colorectal Adenocarcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.